Enfusion, Inc.

ENFN

Find Out if You Qualify for a Financial Reward by filling out the form below.

Enfusion, Inc. Form












Class Action Lawsuit List does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Enfusion conducted its initial public offering (“IPO”) on or around October 21, 2021, selling 15.32 million shares of stock priced at $17.00 per share. Then, on August 6, 2024, Enfusion issued a press release reporting its financial results for the second quarter of 2024. Among other items, Enfusion reported non-GAAP earnings per share of $0.05, missing consensus estimates by $0.01, as well as revenue of $49.5 million, missing consensus estimates by approximately $475,000.

Following this news, Enfusion’s stock price dropped over 7% on August 6, 2024.

Active Cases

Ticker Symbol Company Name Join Deadline Join
EW Edwards Lifesciences Corporation December 13, 2024 Join
TD The Toronto-Dominion Bank December 23, 2024 Join
WOLF Wolfspeed, Inc. January 17, 2025 Join